Canopy Growth Corporation’s Apollo Cannabis Clinics Earn Top Honor in 2025 Toronto Star Readers’ Choice Awards
SMITH FALLS, Ontario—Canopy Growth Corporation (“Canopy Growth” or “the Company”) has announced that its healthcare arm, Apollo Cannabis Clinics (“Apollo”), has been named Best Medical Cannabis Clinic in the 2025 Toronto Star Readers’ Choice Awards. This recognition, determined entirely by public voting, highlights the strong trust and confidence that patients across Canada place in Apollo’s services and care model.
The Toronto Star Readers’ Choice Awards are among the most recognized community-driven accolades in Canada, celebrating businesses and service providers that consistently deliver excellence. Winners are selected solely based on nominations and votes from the public, making the award a powerful reflection of patient satisfaction and real-world impact. Apollo’s recognition in this category underscores its growing reputation as a leader in the delivery of accessible, patient-focused medical cannabis care.
A Patient-Centered Approach to Medical Cannabis
Apollo Cannabis Clinics represent Canopy Growth’s broader mission to elevate the standard of medical cannabis treatment while ensuring accessibility for patients nationwide. By combining clinical expertise with a digital-first approach, Apollo has successfully created a model that prioritizes convenience, education, and ongoing support.
A key differentiator for Apollo is its fully virtual consultation system, which allows patients across Canada to access care without geographic limitations. The service is offered free of charge and does not require a referral, removing common barriers that often prevent individuals from seeking specialized treatment. Through this model, patients can connect with healthcare professionals from the comfort of their homes, making medical cannabis more approachable and inclusive.
Each patient receives a personalized treatment plan tailored to their specific medical needs. Apollo clinicians take into account individual health conditions, treatment history, and lifestyle factors before recommending cannabis-based therapies. In addition to initial consultations, patients benefit from continuous follow-up care, educational resources, and ongoing adjustments to their treatment plans as needed.
Leadership Perspective on the Recognition
Luc Mongeau, Chief Executive Officer of Canopy Growth, emphasized the significance of the award, particularly because it comes directly from patients:
This recognition comes directly from the people we care for, and that makes it especially meaningful. Everything Apollo does is grounded in a genuine commitment to positive patient outcomes. Our team works tirelessly to ensure that medical cannabis care is not only accessible but also supportive and effective. To have that trust validated by so many Canadians is something we deeply value.”
His statement reflects the Company’s focus on patient outcomes over product promotion, reinforcing the importance of trust and transparency in the evolving cannabis healthcare landscape.
Addressing a Wide Range of Medical Conditions
Apollo Cannabis Clinics have supported thousands of Canadians in managing a variety of health conditions through evidence-based cannabis therapies. These include:
- Chronic pain
- Anxiety and stress-related disorders
- Sleep disturbances and insomnia
- Post-traumatic stress disorder (PTSD)
- Other complex and chronic medical conditions
By integrating medical cannabis into broader care strategies, Apollo helps patients explore alternative or complementary treatments where traditional approaches may have been insufficient or produced unwanted side effects.
Education is also a cornerstone of Apollo’s care model. Patients are guided through the safe and responsible use of medical cannabis, ensuring they understand dosage, potential effects, and how to incorporate treatment into their daily lives effectively.
Expanding Access Through Innovation
One of Apollo’s most impactful contributions to the healthcare space is its commitment to accessibility. The clinic’s virtual platform eliminates logistical challenges such as travel time, clinic waitlists, and regional disparities in healthcare availability. This is particularly important in rural or underserved areas, where access to specialized medical cannabis expertise may otherwise be limited.
By leveraging technology, Apollo has positioned itself at the forefront of a broader shift toward telehealth solutions in Canada, aligning with evolving patient expectations for convenience and efficiency in healthcare delivery.
Canopy Growth’s Broader Medical Ecosystem
Apollo Cannabis Clinics operate as part of Canopy Growth’s expansive medical cannabis ecosystem, which is designed to support patients through multiple channels. The Company remains one of Canada’s leading providers of medical cannabis services, combining clinical care, product innovation, and distribution capabilities.
Through its subsidiary Canada House Clinics Inc., Canopy Growth operates a network of physical clinics that collaborate with primary care providers to deliver specialized cannabinoid therapy. This hybrid approach—combining in-person and virtual care—ensures that patients have access to the level of support best suited to their needs.
Additionally, Abba Medix, the Company’s established online medical platform, serves as a major distribution channel for medical cannabis products. Together, these services enable Canopy Growth to reach patients across Canada efficiently, ensuring continuity of care from consultation to treatment access.
A Diverse Portfolio of Cannabis Brands
Beyond its clinical services, Canopy Growth is recognized globally for its portfolio of innovative cannabis brands. These include well-known names such as Tweed, 7ACRES, DOJA, Deep Space, Claybourne, MTL Cannabis, Low Key by MTL, and R’belle. The Company also offers premium vaporization devices through its Storz & Bickel brand, further enhancing its product ecosystem.
This diversified portfolio allows Canopy Growth to address a wide range of consumer and patient preferences, reinforcing its leadership position in both medical and recreational cannabis markets.
Strategic Positioning in the U.S. Market
Canopy Growth has also taken significant steps to expand its presence in the United States through its interest in Canopy USA, an entity designed to capitalize on opportunities in the evolving U.S. THC market.
Canopy USA’s portfolio includes ownership stakes in several prominent cannabis companies, such as Acreage Holdings, Inc., Wana Wellness, LLC, The Cima Group, LLC, Mountain High Products, LLC, and Lemurian, Inc. These investments provide Canopy Growth with exposure to key segments of the U.S. cannabis industry, including edibles, extracts, and multi-state operations.
While these operations remain strategically separate, they form part of a long-term vision to build a comprehensive, cross-border cannabis ecosystem.
Shaping the Future of Cannabis Care
At its core, Canopy Growth is driven by a mission to unlock the full potential of cannabis as a tool for improving lives. The recognition of Apollo Cannabis Clinics as the Best Medical Cannabis Clinic in the 2025 Toronto Star Readers’ Choice Awards is a testament to that mission in action.
By prioritizing patient care, investing in accessible healthcare solutions, and maintaining a strong commitment to quality and education, Apollo continues to set a benchmark in the medical cannabis field.
As public understanding of cannabis evolves and acceptance grows, organizations like Apollo play a critical role in ensuring that patients receive safe, effective, and informed treatment options. This latest accolade not only celebrates past achievements but also signals continued momentum in advancing the role of medical cannabis within mainstream healthcare.
About Apollo Cannabis Clinics
Apollo Cannabis Clinics is Canada’s leading network of medical cannabis clinics, providing free, fully virtual care to patients across the country. Founded on a foundation of clinical research, Apollo connects Canadians with licensed healthcare practitioners for personalized, evidence-based medical cannabis treatment. Learn more at apollocannabis.ca.
About Canopy Growth
Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives.
Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, Claybourne, MTL Cannabis, Low Key by MTL, and R’belle, as well as category defining vaporization devices by Storz & Bickel.
Canopy Growth is Canada’s leading provider of medical cannabis services. Through Canada House Clinics Inc., the Company operates clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions. Abba Medix, Canopy Growth’s established online medical channel, serves as a leading distributor of medical cannabis in Canada, together expanding the Company’s ability to reach and support patients nationwide and internationally.
Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA. Canopy USA’s portfolio includes ownership of Acreage Holdings, Inc., a vertically integrated multi‑state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness, LLC, The Cima Group, LLC, and Mountain High Products, LLC, a leading North American edibles brand, and majority ownership of Lemurian, Inc., a California-based producer of high-quality cannabis extracts and clean vape technology.
At Canopy Growth, we’re shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we’re paving the way for a better understanding of all that cannabis can offer.
